Ahmed Enayetallah

Ahmed Enayetallah is an accomplished professional in clinical development and research, currently serving as the Head of R&D - Development at Dompé since May 2024. Previously, Ahmed held several senior roles at BlueRock Therapeutics, including Head of Development and Senior Vice President - Head of Clinical Development, Product Development, and Formulation. Prior experience includes notable positions at Alexion Pharmaceuticals, Amgen, and Biogen Idec, focusing on neurology and ophthalmology. Educational qualifications include a PhD in Pharmacology/Toxicology from the University of Connecticut and an MB.BCh in Medicine and Surgery from Cairo University.